Literature DB >> 34917320

Functional abdominal pain in adolescents: case-based management.

Desale Yacob1,2, Ashley M Kroon Van Diest2,3, Carlo Di Lorenzo1,2.   

Abstract

Functional gastrointestinal disorders (FGIDs), including functional abdominal pain (FAP), account for a large portion of conditions seen by paediatric gastroenterologists. Despite the commonality of FGIDs, there remains significant stigma around these diagnoses among medical providers, patients and families. This is due to the absence of easily identifiable biological markers in FGIDs and the overlay with psychological and social factors contributing to symptom onset and maintenance. As such, the biopsychosocial model is essential in conceptualising, evaluating and treating FGIDs. The way in which medical providers explain FGIDs and the manner in which they collaborate with other specialists (eg, psychologists, dieticians, physical therapists, school nurses) is paramount to the patient and family acceptance of an FGID diagnosis and the success of subsequent treatment. The following review outlines paediatric FGIDs with a focus on FAP in adolescents, in particular within the context of the biopsychosocial approach to pathophysiology, diagnosis and treatment. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  abdominal pain; functional bowel disorder; functional dyspepsia; irritable bowel syndrome; psychological stress

Year:  2020        PMID: 34917320      PMCID: PMC8640410          DOI: 10.1136/flgastro-2020-101572

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  70 in total

1.  Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome.

Authors:  K Kroenke; A D Mangelsdorff
Journal:  Am J Med       Date:  1989-03       Impact factor: 4.965

2.  Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Carlo Di Lorenzo; Richard B Colletti; Harold P Lehmann; John T Boyle; William T Gerson; Jeffrey S Hyams; Robert H Squires; Lynn S Walker; Pamela T Kanda
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-03       Impact factor: 2.839

3.  Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire.

Authors:  W G Thompson; E J Irvine; P Pare; S Ferrazzi; L Rance
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

4.  Evaluation of a cognitive-behavioral pain management program for children with chronic abdominal pain: a randomized controlled study.

Authors:  Martina Groß; Petra Warschburger
Journal:  Int J Behav Med       Date:  2013-09

5.  Recurrent abdominal pain syndrome in a cohort of Sri Lankan children and adolescents.

Authors:  Niranga Manjuri Devanarayana; Delpechitracharige Gajabahu Harendra de Silva; Hithanadura Janaka de Silva
Journal:  J Trop Pediatr       Date:  2008-01-19       Impact factor: 1.165

Review 6.  Mind Over Gut: Psychosocial Management of Pediatric Functional Abdominal Pain.

Authors:  Molly R Galdston; Rita M John
Journal:  J Pediatr Health Care       Date:  2016-01-07       Impact factor: 1.812

7.  Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial.

Authors:  H Roohafza; Z Pourmoghaddas; H Saneian; A Gholamrezaei
Journal:  Neurogastroenterol Motil       Date:  2014-09-22       Impact factor: 3.598

Review 8.  Pediatric pain management: the multidisciplinary approach.

Authors:  Shannon Odell; Deirdre E Logan
Journal:  J Pain Res       Date:  2013-11-11       Impact factor: 3.133

Review 9.  Clinical Hypnosis with Children and Adolescents-What? Why? How?: Origins, Applications, and Efficacy.

Authors:  Daniel P Kohen; Pamela Kaiser
Journal:  Children (Basel)       Date:  2014-08-12

Review 10.  What Is New in Rome IV.

Authors:  Max J Schmulson; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.